 | • レポートコード：QY2207C3691 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のクローニングサービスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にクローニングサービスの世界市場のxxx％を占める「標準遺伝子」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「タンパク質発現＆精製」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のクローニングサービスの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのクローニングサービス市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのクローニングサービス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 クローニングサービスのグローバル主要メーカーには、Genscript、Eurofins Genomics、Azenta、Creative Biogene、OriGene、Thermo Fisher Scientific、Applied Biological Materials、Charles River、BioServUK、GW Vitek、Canvax、Synbio Technologies、Bioneer Corporation、GENEWIZ、Epoch Life Science、Inovogen Tech、Abace Biotechnologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 クローニングサービス市場は、種類と用途によって区分されます。世界のクローニングサービス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 標準遺伝子、複合遺伝子、その他 【用途別セグメント】 タンパク質発現＆精製、遺伝子工学、ワクチン研究、遺伝子治療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - クローニングサービス製品概要 - 種類別市場（標準遺伝子、複合遺伝子、その他） - 用途別市場（タンパク質発現＆精製、遺伝子工学、ワクチン研究、遺伝子治療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のクローニングサービス販売量予測2017-2028 - 世界のクローニングサービス売上予測2017-2028 - クローニングサービスの地域別販売量 - クローニングサービスの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別クローニングサービス販売量 - 主要メーカー別クローニングサービス売上 - 主要メーカー別クローニングサービス価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（標準遺伝子、複合遺伝子、その他） - クローニングサービスの種類別販売量 - クローニングサービスの種類別売上 - クローニングサービスの種類別価格 ・用途別市場規模（タンパク質発現＆精製、遺伝子工学、ワクチン研究、遺伝子治療、その他） - クローニングサービスの用途別販売量 - クローニングサービスの用途別売上 - クローニングサービスの用途別価格 ・北米市場 - 北米のクローニングサービス市場規模（種類別、用途別） - 主要国別のクローニングサービス市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのクローニングサービス市場規模（種類別、用途別） - 主要国別のクローニングサービス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のクローニングサービス市場規模（種類別、用途別） - 主要国別のクローニングサービス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のクローニングサービス市場規模（種類別、用途別） - 主要国別のクローニングサービス市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのクローニングサービス市場規模（種類別、用途別） - 主要国別のクローニングサービス市場規模（トルコ、サウジアラビア） ・企業情報 Genscript、Eurofins Genomics、Azenta、Creative Biogene、OriGene、Thermo Fisher Scientific、Applied Biological Materials、Charles River、BioServUK、GW Vitek、Canvax、Synbio Technologies、Bioneer Corporation、GENEWIZ、Epoch Life Science、Inovogen Tech、Abace Biotechnology ・産業チェーン及び販売チャネル分析 - クローニングサービスの産業チェーン分析 - クローニングサービスの原材料 - クローニングサービスの生産プロセス - クローニングサービスの販売及びマーケティング - クローニングサービスの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - クローニングサービスの産業動向 - クローニングサービスのマーケットドライバー - クローニングサービスの課題 - クローニングサービスの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Cloning Service Market
The global Cloning Service market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Standard Gene accounting for % of the Cloning Service global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Protein Expression and Purification segment is altered to an % CAGR throughout this forecast period.
China Cloning Service market size is valued at US$ million in 2021, while the North America and Europe Cloning Service are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cloning Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cloning Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cloning Service market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cloning Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cloning Service market.
Global Cloning Service Scope and Market Size
Cloning Service market is segmented by players, region (country), by Gene Type and by Application. Players, stakeholders, and other participants in the global Cloning Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Gene Type and by Application for the period 2017-2028.
Segment by Gene Type
Standard Gene
Complex Gene
Other Gene Type
Segment by Application
Protein Expression and Purification
Genetic Engineering
Vaccine Research
Gene Therapy
Others
By Company
Genscript
Eurofins Genomics
Azenta
Creative Biogene
OriGene
Thermo Fisher Scientific
Applied Biological Materials
Charles River
BioServUK
GW Vitek
Canvax
Synbio Technologies
Bioneer Corporation
GENEWIZ
Epoch Life Science
Inovogen Tech
Abace Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Gene Type
1.2.1 Global Cloning Service Market Size Growth Rate by Gene Type, 2017 VS 2021 VS 2028
1.2.2 Standard Gene
1.2.3 Complex Gene
1.2.4 Other Gene Type
1.3 Market by Application
1.3.1 Global Cloning Service Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Protein Expression and Purification
1.3.3 Genetic Engineering
1.3.4 Vaccine Research
1.3.5 Gene Therapy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cloning Service Market Perspective (2017-2028)
2.2 Cloning Service Growth Trends by Region
2.2.1 Cloning Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cloning Service Historic Market Size by Region (2017-2022)
2.2.3 Cloning Service Forecasted Market Size by Region (2023-2028)
2.3 Cloning Service Market Dynamics
2.3.1 Cloning Service Industry Trends
2.3.2 Cloning Service Market Drivers
2.3.3 Cloning Service Market Challenges
2.3.4 Cloning Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cloning Service Players by Revenue
3.1.1 Global Top Cloning Service Players by Revenue (2017-2022)
3.1.2 Global Cloning Service Revenue Market Share by Players (2017-2022)
3.2 Global Cloning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cloning Service Revenue
3.4 Global Cloning Service Market Concentration Ratio
3.4.1 Global Cloning Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cloning Service Revenue in 2021
3.5 Cloning Service Key Players Head office and Area Served
3.6 Key Players Cloning Service Product Solution and Service
3.7 Date of Enter into Cloning Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cloning Service Breakdown Data by Gene Type
4.1 Global Cloning Service Historic Market Size by Gene Type (2017-2022)
4.2 Global Cloning Service Forecasted Market Size by Gene Type (2023-2028)
5 Cloning Service Breakdown Data by Application
5.1 Global Cloning Service Historic Market Size by Application (2017-2022)
5.2 Global Cloning Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cloning Service Market Size (2017-2028)
6.2 North America Cloning Service Market Size by Gene Type
6.2.1 North America Cloning Service Market Size by Gene Type (2017-2022)
6.2.2 North America Cloning Service Market Size by Gene Type (2023-2028)
6.2.3 North America Cloning Service Market Share by Gene Type (2017-2028)
6.3 North America Cloning Service Market Size by Application
6.3.1 North America Cloning Service Market Size by Application (2017-2022)
6.3.2 North America Cloning Service Market Size by Application (2023-2028)
6.3.3 North America Cloning Service Market Share by Application (2017-2028)
6.4 North America Cloning Service Market Size by Country
6.4.1 North America Cloning Service Market Size by Country (2017-2022)
6.4.2 North America Cloning Service Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cloning Service Market Size (2017-2028)
7.2 Europe Cloning Service Market Size by Gene Type
7.2.1 Europe Cloning Service Market Size by Gene Type (2017-2022)
7.2.2 Europe Cloning Service Market Size by Gene Type (2023-2028)
7.2.3 Europe Cloning Service Market Share by Gene Type (2017-2028)
7.3 Europe Cloning Service Market Size by Application
7.3.1 Europe Cloning Service Market Size by Application (2017-2022)
7.3.2 Europe Cloning Service Market Size by Application (2023-2028)
7.3.3 Europe Cloning Service Market Share by Application (2017-2028)
7.4 Europe Cloning Service Market Size by Country
7.4.1 Europe Cloning Service Market Size by Country (2017-2022)
7.4.2 Europe Cloning Service Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cloning Service Market Size (2017-2028)
8.2 Asia-Pacific Cloning Service Market Size by Gene Type
8.2.1 Asia-Pacific Cloning Service Market Size by Gene Type (2017-2022)
8.2.2 Asia-Pacific Cloning Service Market Size by Gene Type (2023-2028)
8.2.3 Asia-Pacific Cloning Service Market Share by Gene Type (2017-2028)
8.3 Asia-Pacific Cloning Service Market Size by Application
8.3.1 Asia-Pacific Cloning Service Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cloning Service Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cloning Service Market Share by Application (2017-2028)
8.4 Asia-Pacific Cloning Service Market Size by Region
8.4.1 Asia-Pacific Cloning Service Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cloning Service Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cloning Service Market Size (2017-2028)
9.2 Latin America Cloning Service Market Size by Gene Type
9.2.1 Latin America Cloning Service Market Size by Gene Type (2017-2022)
9.2.2 Latin America Cloning Service Market Size by Gene Type (2023-2028)
9.2.3 Latin America Cloning Service Market Share by Gene Type (2017-2028)
9.3 Latin America Cloning Service Market Size by Application
9.3.1 Latin America Cloning Service Market Size by Application (2017-2022)
9.3.2 Latin America Cloning Service Market Size by Application (2023-2028)
9.3.3 Latin America Cloning Service Market Share by Application (2017-2028)
9.4 Latin America Cloning Service Market Size by Country
9.4.1 Latin America Cloning Service Market Size by Country (2017-2022)
9.4.2 Latin America Cloning Service Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cloning Service Market Size (2017-2028)
10.2 Middle East & Africa Cloning Service Market Size by Gene Type
10.2.1 Middle East & Africa Cloning Service Market Size by Gene Type (2017-2022)
10.2.2 Middle East & Africa Cloning Service Market Size by Gene Type (2023-2028)
10.2.3 Middle East & Africa Cloning Service Market Share by Gene Type (2017-2028)
10.3 Middle East & Africa Cloning Service Market Size by Application
10.3.1 Middle East & Africa Cloning Service Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cloning Service Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cloning Service Market Share by Application (2017-2028)
10.4 Middle East & Africa Cloning Service Market Size by Country
10.4.1 Middle East & Africa Cloning Service Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cloning Service Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genscript
11.1.1 Genscript Company Details
11.1.2 Genscript Business Overview
11.1.3 Genscript Cloning Service Introduction
11.1.4 Genscript Revenue in Cloning Service Business (2017-2022)
11.1.5 Genscript Recent Developments
11.2 Eurofins Genomics
11.2.1 Eurofins Genomics Company Details
11.2.2 Eurofins Genomics Business Overview
11.2.3 Eurofins Genomics Cloning Service Introduction
11.2.4 Eurofins Genomics Revenue in Cloning Service Business (2017-2022)
11.2.5 Eurofins Genomics Recent Developments
11.3 Azenta
11.3.1 Azenta Company Details
11.3.2 Azenta Business Overview
11.3.3 Azenta Cloning Service Introduction
11.3.4 Azenta Revenue in Cloning Service Business (2017-2022)
11.3.5 Azenta Recent Developments
11.4 Creative Biogene
11.4.1 Creative Biogene Company Details
11.4.2 Creative Biogene Business Overview
11.4.3 Creative Biogene Cloning Service Introduction
11.4.4 Creative Biogene Revenue in Cloning Service Business (2017-2022)
11.4.5 Creative Biogene Recent Developments
11.5 OriGene
11.5.1 OriGene Company Details
11.5.2 OriGene Business Overview
11.5.3 OriGene Cloning Service Introduction
11.5.4 OriGene Revenue in Cloning Service Business (2017-2022)
11.5.5 OriGene Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Cloning Service Introduction
11.6.4 Thermo Fisher Scientific Revenue in Cloning Service Business (2017-2022)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 Applied Biological Materials
11.7.1 Applied Biological Materials Company Details
11.7.2 Applied Biological Materials Business Overview
11.7.3 Applied Biological Materials Cloning Service Introduction
11.7.4 Applied Biological Materials Revenue in Cloning Service Business (2017-2022)
11.7.5 Applied Biological Materials Recent Developments
11.8 Charles River
11.8.1 Charles River Company Details
11.8.2 Charles River Business Overview
11.8.3 Charles River Cloning Service Introduction
11.8.4 Charles River Revenue in Cloning Service Business (2017-2022)
11.8.5 Charles River Recent Developments
11.9 BioServUK
11.9.1 BioServUK Company Details
11.9.2 BioServUK Business Overview
11.9.3 BioServUK Cloning Service Introduction
11.9.4 BioServUK Revenue in Cloning Service Business (2017-2022)
11.9.5 BioServUK Recent Developments
11.10 GW Vitek
11.10.1 GW Vitek Company Details
11.10.2 GW Vitek Business Overview
11.10.3 GW Vitek Cloning Service Introduction
11.10.4 GW Vitek Revenue in Cloning Service Business (2017-2022)
11.10.5 GW Vitek Recent Developments
11.11 Canvax
11.11.1 Canvax Company Details
11.11.2 Canvax Business Overview
11.11.3 Canvax Cloning Service Introduction
11.11.4 Canvax Revenue in Cloning Service Business (2017-2022)
11.11.5 Canvax Recent Developments
11.12 Synbio Technologies
11.12.1 Synbio Technologies Company Details
11.12.2 Synbio Technologies Business Overview
11.12.3 Synbio Technologies Cloning Service Introduction
11.12.4 Synbio Technologies Revenue in Cloning Service Business (2017-2022)
11.12.5 Synbio Technologies Recent Developments
11.13 Bioneer Corporation
11.13.1 Bioneer Corporation Company Details
11.13.2 Bioneer Corporation Business Overview
11.13.3 Bioneer Corporation Cloning Service Introduction
11.13.4 Bioneer Corporation Revenue in Cloning Service Business (2017-2022)
11.13.5 Bioneer Corporation Recent Developments
11.14 GENEWIZ
11.14.1 GENEWIZ Company Details
11.14.2 GENEWIZ Business Overview
11.14.3 GENEWIZ Cloning Service Introduction
11.14.4 GENEWIZ Revenue in Cloning Service Business (2017-2022)
11.14.5 GENEWIZ Recent Developments
11.15 Epoch Life Science
11.15.1 Epoch Life Science Company Details
11.15.2 Epoch Life Science Business Overview
11.15.3 Epoch Life Science Cloning Service Introduction
11.15.4 Epoch Life Science Revenue in Cloning Service Business (2017-2022)
11.15.5 Epoch Life Science Recent Developments
11.16 Inovogen Tech
11.16.1 Inovogen Tech Company Details
11.16.2 Inovogen Tech Business Overview
11.16.3 Inovogen Tech Cloning Service Introduction
11.16.4 Inovogen Tech Revenue in Cloning Service Business (2017-2022)
11.16.5 Inovogen Tech Recent Developments
11.17 Abace Biotechnology
11.17.1 Abace Biotechnology Company Details
11.17.2 Abace Biotechnology Business Overview
11.17.3 Abace Biotechnology Cloning Service Introduction
11.17.4 Abace Biotechnology Revenue in Cloning Service Business (2017-2022)
11.17.5 Abace Biotechnology Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer